MNO lab presents 8 abstracts at the 22nd Annual Scientific Meeting of the Society for Neuro-Oncology


Written on November 27th, 2017

The Mathematical Neuro-oncology Lab had a strong showing at the 2017 Society for Neuro-Oncology annual meeting. Eight members presented a variety of research ranging from the evaluation of response metrics in GBM treatment to novel methods for applying machine learning methods to radiomics.

404 Not Found

404 Not Found


nginx
  • Gustavo De Leon, BS – “Identifying Early Indicators of Immunotherapeutic Response: CAR T-Cell Therapy”
  • Susan Christine Massey, PhD – “Extent of glioblastoma invasion predicts overall survival following upfront radiotherapy concurrent with temozolomide”
  • Kyle W. Singleton, PhD – “Discrimination of clinically impactful treatment response in recurrent glioblastoma patients receiving bevacizumab treatment”
  • Kyle W. Singleton, PhD – “Role of pretreatment tumor dynamics and imaging response in discriminating glioblastoma survival following gamma knife”
  • Michael Vogelbaum, MD, PhD – “Impact of post-surgical enhancing tumor volume and T2/FLAIR volume on the survival impact of bevacizumab in NRG Oncology/ RTOG 0825”
  • Pamela R Jackson, PhD – “P53 amplification modifies the glioblastoma microenvironment: Differentiating the contribution of cells vs edema in the T2 weighted MRI signal”
  • Leland Hu, MD – “Accurate patient-specific machine learning models of glioblastoma invasion using transfer learning”
  • Kristin R Swanson, PhD – “Radiomics of tumor invasion 2.0: combining mechanistic tumor invasion models with machine learning models to accurately predict tumor invasion in human glioblastoma patients”


© 2017 Mathematical NeuroOncology (MNO). Website designed by Mihafa.com.

.